137 related articles for article (PubMed ID: 32633140)
1. Anticipation on age at onset in kindreds with hereditary ATTRV30M amyloidosis from the Majorcan cluster.
Cisneros-Barroso E; González-Moreno J; Rodríguez A; Ripoll-Vera T; Álvarez J; Usón M; Figuerola A; Descals C; Montalá C; Ferrer-Nadal MA; Losada I
Amyloid; 2020 Dec; 27(4):254-258. PubMed ID: 32633140
[TBL] [Abstract][Full Text] [Related]
2. New data on the genetic profile and penetrance of hereditary Val30Met transthyretin amyloidosis in Sweden.
Gorram F; Olsson M; Alarcon F; Nuel G; Anan I; Planté-Bordeneuve V
Amyloid; 2021 Jun; 28(2):84-90. PubMed ID: 33146042
[TBL] [Abstract][Full Text] [Related]
3. Overcoming artefact: anticipation in 284 Portuguese kindreds with familial amyloid polyneuropathy (FAP) ATTRV30M.
Lemos C; Coelho T; Alves-Ferreira M; Martins-da-Silva A; Sequeiros J; Mendonça D; Sousa A
J Neurol Neurosurg Psychiatry; 2014 Mar; 85(3):326-30. PubMed ID: 24046394
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology of ATTRV30M neuropathy in Cyprus and the modifier effect of complement C1q on the age of disease onset.
Andreou S; Panayiotou E; Michailidou K; Pirpa P; Hadjisavvas A; El Salloukh A; Barnes D; Antoniou A; Agathangelou P; Papastavrou K; Christodoulou K; Tanteles GA; Kyriakides T
Amyloid; 2018 Dec; 25(4):220-226. PubMed ID: 30572722
[TBL] [Abstract][Full Text] [Related]
5. Genetic and clinical characteristics of hereditary transthyretin amyloidosis in endemic and non-endemic areas: experience from a single-referral center in Japan.
Yamashita T; Ueda M; Misumi Y; Masuda T; Nomura T; Tasaki M; Takamatsu K; Sasada K; Obayashi K; Matsui H; Ando Y
J Neurol; 2018 Jan; 265(1):134-140. PubMed ID: 29177547
[TBL] [Abstract][Full Text] [Related]
6. Transthyretin familial amyloid polyneuropathy (TTR-FAP) in Mallorca: a comparison between late- and early-onset disease.
Buades-Reinés J; Raya-Cruz M; Gallego-Lezaún C; Ripoll-Vera T; Usón-Martín M; Andreu-Serra H; Cisneros-Barroso E
J Peripher Nerv Syst; 2016 Dec; 21(4):352-356. PubMed ID: 27403623
[TBL] [Abstract][Full Text] [Related]
7. Cardiac involvement in a large cohort of patients with Val30Met transthyretin amyloidosis from Majorca focus.
Ripoll-Vera T; Alvarez J; Buades J; Cisneros E; Gomez Y; Melia C; Ferrer A; Losada I; Gonzalez J; Uson M; Figuerola A
Amyloid; 2019; 26(sup1):15-16. PubMed ID: 31343338
[No Abstract] [Full Text] [Related]
8. A Trans-acting Factor May Modify Age at Onset in Familial Amyloid Polyneuropathy ATTRV30M in Portugal.
Alves-Ferreira M; Coelho T; Santos D; Sequeiros J; Alonso I; Sousa A; Lemos C
Mol Neurobiol; 2018 May; 55(5):3676-3683. PubMed ID: 28527106
[TBL] [Abstract][Full Text] [Related]
9. Disease risk estimates in V30M variant transthyretin amyloidosis (A-ATTRv) from Mallorca.
Cisneros-Barroso E; Gorram F; Ribot-Sansó MA; Alarcon F; Nuel G; González-Moreno J; Rodríguez A; Hernandez-Rodriguez J; Amengual-Cladera E; Martínez-López I; Ripoll-Vera T; Losada-López I; Heine-Suñer D; Plante-Bordeneuve V
Orphanet J Rare Dis; 2023 Aug; 18(1):255. PubMed ID: 37653545
[TBL] [Abstract][Full Text] [Related]
10. Beyond Val30Met transthyretin (TTR): variants associated with age-at-onset in hereditary ATTRv amyloidosis.
Alves-Ferreira M; Azevedo A; Coelho T; Santos D; Sequeiros J; Alonso I; Sousa A; Lemos C
Amyloid; 2021 Jun; 28(2):100-106. PubMed ID: 33461327
[TBL] [Abstract][Full Text] [Related]
11. A multicentric study of the disease risks and first manifestations in hereditary transthyretin amyloidosis (ATTRv): insights for an earlier diagnosis.
Planté-Bordeneuve V; Gorram F; Olsson M; Anan I; Mazzeo A; Gentile L; Cisneros-Barroso E; Gonzalez-Moreno J; Losada I; Waddington-Cruz M; Pinto LF; Parman Y; Fanen P; Alarcon F; Nuel G
Amyloid; 2023 Sep; 30(3):313-320. PubMed ID: 36994840
[TBL] [Abstract][Full Text] [Related]
12. Ophthalmological manifestations in hereditary transthyretin (ATTR V30M) carriers: a review of 513 cases.
Beirão JM; Malheiro J; Lemos C; Beirão I; Costa P; Torres P
Amyloid; 2015; 22(2):117-22. PubMed ID: 26096568
[TBL] [Abstract][Full Text] [Related]
13. mtDNA copy number associated with age of onset in familial amyloid polyneuropathy.
Santos D; Santos MJ; Alves-Ferreira M; Coelho T; Sequeiros J; Alonso I; Oliveira P; Sousa A; Lemos C; Grazina M
J Neurol Neurosurg Psychiatry; 2018 Mar; 89(3):300-304. PubMed ID: 29018163
[TBL] [Abstract][Full Text] [Related]
14. A case report of osteoarthritis associated with hereditary transthyretin amyloidosis ATTRV30M.
Anan I; Bång J; Lundgren HE; Wixner J; Westermark P
Amyloid; 2019; 26(sup1):29-30. PubMed ID: 31343355
[No Abstract] [Full Text] [Related]
15. Evolution of amyloid fibrils in hereditary transthyretin amyloidosis: an ultrastructural study.
Koike H; Nishi R; Ikeda S; Kawagashira Y; Iijima M; Katsuno M; Sobue G
Amyloid; 2019; 26(sup1):26. PubMed ID: 31343346
[No Abstract] [Full Text] [Related]
16. The frequency of central nervous system complications in the Cypriot cohort of ATTRV30M neuropathy transplanted patients.
Dardiotis E; Andreou S; Aloizou AM; Panayiotou E; Siokas V; Ioannou MN; Vounou E; Christodoulou K; Tanteles GA; Michaelides D; Kyriakides T
Neurol Sci; 2020 May; 41(5):1163-1170. PubMed ID: 31897943
[TBL] [Abstract][Full Text] [Related]
17. Variants in RBP4 and AR genes modulate age at onset in familial amyloid polyneuropathy (FAP ATTRV30M).
Santos D; Coelho T; Alves-Ferreira M; Sequeiros J; Mendonça D; Alonso I; Lemos C; Sousa A
Eur J Hum Genet; 2016 May; 24(5):756-60. PubMed ID: 26286643
[TBL] [Abstract][Full Text] [Related]
18. The sensitivity of DPD scintigraphy to detect transthyretin cardiac amyloidosis in V30M mutation depends on the phenotypic expression of the disease.
Azevedo Coutinho MC; Cortez-Dias N; Cantinho G; Gonçalves S; Menezes MN; Guimarães T; Lima da Silva G; Francisco AR; Agostinho J; Santos L; Conceição I; Pinto FJ
Amyloid; 2020 Sep; 27(3):174-183. PubMed ID: 32482106
[No Abstract] [Full Text] [Related]
19. C1q ablation exacerbates amyloid deposition: A study in a transgenic mouse model of ATTRV30M amyloid neuropathy.
Panayiotou E; Fella E; Papacharalambous R; Malas S; Saraiva MJ; Kyriakides T
PLoS One; 2017; 12(4):e0175767. PubMed ID: 28407005
[TBL] [Abstract][Full Text] [Related]
20. The current status of the Transthyretin Amyloidosis Outcomes Survey (THAOS) in Japan.
Sekijima Y; Mundayat R; Ishii T; Ando Y
Amyloid; 2019; 26(sup1):61-62. PubMed ID: 31343365
[No Abstract] [Full Text] [Related]
[Next] [New Search]
